Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 05 11 2021
accepted: 14 04 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

The identification and treatment of latent tuberculosis infection (LTBI) among immigrants from high-incidence regions who move to low-incidence countries is generally considered an ineffective strategy because only ≈14% of them comply with the multiple steps of the 'cascade of care' and complete treatment. In the Estrie region of Canada, a refugee clinic was opened in 2009. One of its goals is LTBI management. Key components of this intervention included: close collaboration with community organizations, integration within a comprehensive package of medical care for the whole family, timely delivery following arrival, shorter treatment through preferential use of rifampin, and risk-based selection of patients to be treated. Between 2009-2020, 5131 refugees were evaluated. To determine the efficacy and benefit-cost ratio of this intervention, records of refugees seen in 2010-14 (n = 1906) and 2018-19 (n = 1638) were reviewed. Cases of tuberculosis (TB) among our foreign-born population occurring before (1997-2008) and after (2009-2020) setting up the clinic were identified. All costs associated with TB or LTBI were measured. Out of 441 patients offered LTBI treatment, 374 (85%) were compliant. Adding other losses, overall compliance was 69%. To prevent one case of TB, 95.1 individuals had to be screened and 11.9 treated, at a cost of $16,056. After discounting, each case of TB averted represented $32,631, for a benefit-cost ratio of 2.03. Among nationals of the 20 countries where refugees came from, incidence of TB decreased from 68.2 (1997-2008) to 26.3 per 100,000 person-years (2009-2020). Incidence among foreign-born persons from all other countries not targeted by the intervention did not change. Among refugees settling in our region, 69% completed the LTBI cascade of care, leading to a 61% reduction in TB incidence. This intervention was cost-beneficial. Current defeatism towards LTBI management among immigrants and refugees is misguided. Compliance can be enhanced through simple measures.

Identifiants

pubmed: 35587499
doi: 10.1371/journal.pone.0267781
pii: PONE-D-21-35333
pmc: PMC9119458
doi:

Banques de données

Dryad
['10.5061/dryad.n8pk0p2wm']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0267781

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Infect Dis. 2016 Nov;16(11):1269-1278
pubmed: 27522233
Front Public Health. 2019 Mar 21;7:57
pubmed: 30949466
Int J Tuberc Lung Dis. 2008 May;12(5):498-505
pubmed: 18419884
N Engl J Med. 2018 Aug 2;379(5):454-463
pubmed: 30067928
Can Respir J. 2016;2016:7980869
pubmed: 27445565
BMJ. 2020 Mar 10;368:m549
pubmed: 32156698
Ann Intern Med. 2020 Aug 4;173(3):169-178
pubmed: 32539440
Am J Epidemiol. 2022 Jan 24;191(2):255-270
pubmed: 34017976
BMC Infect Dis. 2016 May 17;16:204
pubmed: 27184748
BMC Infect Dis. 2016 Nov 15;16(1):679
pubmed: 27846812
N Engl J Med. 2018 Aug 2;379(5):440-453
pubmed: 30067931
Clin Infect Dis. 2021 Nov 2;73(9):e3486-e3495
pubmed: 32556316
CMAJ. 2011 Sep 6;183(12):E939-51
pubmed: 20634392
Value Health. 2008 Sep-Oct;11(5):842-52
pubmed: 18489519
Can Commun Dis Rep. 2019 Feb 07;45(2-3):67-74
pubmed: 31015821
CMAJ. 2018 Feb 26;190(8):E209-E216
pubmed: 29483329
Clin Infect Dis. 2019 Nov 27;69(12):2101-2108
pubmed: 30856258
CMAJ. 2015 Nov 3;187(16):E473-E481
pubmed: 26416993
Nat Med. 2020 Dec;26(12):1941-1949
pubmed: 33077958
Eur Respir J. 2011 Oct;38(4):895-902
pubmed: 21436350
Int J Tuberc Lung Dis. 2007 Jan;11(1):16-26
pubmed: 17217125
Can J Public Health. 2008 Sep-Oct;99(5):391-6
pubmed: 19009923

Auteurs

Jacques Pépin (J)

Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.

France Desjardins (F)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Alex Carignan (A)

Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Michel Lambert (M)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Isabelle Vaillancourt (I)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Christiane Labrie (C)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Dominique Mercier (D)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Rachel Bourque (R)

Clinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.

Louiselle LeBlanc (L)

Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH